Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?


About 2% of the world's population is estimated to be chronically infected with hepatitis C virus (HCV). These chronic carriers are at risk of developing liver cirrhosis and its complications. Successful treatment of HCV infection is associated with improved quality of life and increased survival. Antiviral approaches were formerly based on interferon and… (More)
DOI: 10.1586/14787210.2014.929497


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics